92.56k followers • 21 symbols Watchlist by Yahoo Finance
Follow this list to discover and track the stock of publicly traded companies with exposure to cannabis
Anheuser-Busch InBev SA/NV
Altria Group, Inc.
Molson Coors Brewing Company
Canopy Growth Corporation
Canopy Growth Corporation
The Scotts Miracle-Gro Company
GW Pharmaceuticals plc
Aurora Cannabis Inc.
Cronos Group Inc.
Corbus Pharmaceuticals Holdings, Inc.
The Green Organic Dutchman Holdings Ltd.
New Age Beverages Corporation
The Green Organic Dutchman Holdings Ltd.
CannTrust Holdings Inc.
CannTrust Holdings Inc.
General Cannabis Corp
Terra Tech Corp.
ETFMG Alternative Harvest ETF
(Bloomberg) -- U.S. regulators are hitting the brakes on plans to force tobacco companies to drastically reduce addictive nicotine in cigarettes, retreating on an ambitious public-health initiative that comes amid increasing worry about nicotine use among young people.The Department of Health and Human Services has dropped a proposal unveiled two years ago to cut the level of nicotine in cigarettes to non-addictive levels, according to a regulatory document published on Wednesday.Abandoning the plan, which almost certainly would have meant a sharp reduction in tobacco sales, would be a major victory for the tobacco industry. The move also comes at a time when public debate is focused on the potential for e-cigarettes to create a new generation of nicotine addicts.Representatives for the Food and Drug Administration and the Department of Health and Human Services didn’t immediately respond to requests for comment. Shares of Altria Group Inc., the maker of Marlboro cigarettes, closed up 3.2% in New York. Philip Morris International Inc. was little-changed.In a notice posted on a government website earlier this year as part of the Food and Drug Administration’s near-term regulatory goals, the agency said that the policy “would have significant public health benefits for youth, young adults, and adults, as well as potentially vast economic benefits.”That goal, once included as part of the “unified agenda” of regulations the government is working on, is no longer listed on the website, which was updated Wednesday as part of a semiannual review.FDA spokesman Michael Felberbaum said that the removal of the plans “does not mean the agency does not consider them a priority or will not continue to work on their development.”“The agency has focused on regulations that reflect its most immediate priorities,” Felberbaum said in an email. “FDA continues to gather evidence and data on an ongoing basis regarding all tobacco products.”Ambitious PlanIn 2017, then-FDA Commissioner Scott Gottlieb said he wanted to reduce nicotine levels in cigarettes and other burnt tobacco to near-zero. Almost half a million people in the U.S. die each year from tobacco-related causes, according to the Centers for Disease Control and Prevention, and the move was hailed at the time as a potentially monumental public-health decision. One estimate published in the New England Journal of Medicine projected it could save 2.8 million lives by 2060, and millions more in later decades.“If the FDA abandons its plan to limit nicotine levels in cigarettes, it will miss an unprecedented opportunity to improve health and save lives,“ said Matthew Myers, president of the advocacy group Campaign for Tobacco-Free Kids.The proposal also shocked Wall Street, sending stocks of tobacco giants including Altria plunging as investors reconsidered whether people would bother smoking a cigarette without the addictive chemical. The move was paired with a decision -- later reversed -- to give e-cigarette makers extra time to keep their products on the market without regulation.Gottlieb left the FDA before the nicotine policy could be seen through. Altria later bought a $12.8 billion stake in e-cigarette market leader Juul Labs Inc., a hedge against declining smoking rates.“The effort to lower nicotine in cigarettes is a central part of our effort to reduce death and disease from tobacco,” Gottlieb said in response to a request for comment from Bloomberg. “It’s critical we all maintain our commitment to these public health goals.”Another former FDA commissioner, Robert Califf, said on Twitter that the change marked “a sad day for future grandchildren. They will have fewer grandparents because of this.”Altria spokesman Steven Callahan declined to comment.The update to the U.S. regulatory agenda was published on the same morning that a Senate panel was considering the nomination of Texas oncologist Stephen Hahn to be the new head of the FDA. At that hearing, Hahn was peppered with questions about the agency’s approach to the e-cigarette industry. This year, government data has shown a surge in use of e-cigarettes by teens, and thousands of Americans have suffered serious lung injuries after vaping.The Trump administration had vowed tough curbs on flavored vaping products in September. Since then, however, the president has signaled any effort to clear the market of flavored products that appeal to young people is on hold.The FDA’s oversight of the tobacco industry was the product of a pitched political battle that began in the 1990s and culminated in a 2009 law giving the agency oversight of cigarettes and other smokeless products.Recently, some administration officials have questioned the FDA’s role in regulating tobacco. Joe Grogan, the head of the White House Domestic Policy Council, earlier this month called the FDA’s regulation of tobacco “a huge waste of time” and said the agency should focus on pharmaceuticals.(Updates with estimate on potential lives saved in ninth paragraph)\--With assistance from Tiffany Kary.To contact the reporter on this story: Drew Armstrong in New York at firstname.lastname@example.orgTo contact the editors responsible for this story: Drew Armstrong at email@example.com, Timothy AnnettFor more articles like this, please visit us at bloomberg.com©2019 Bloomberg L.P.
TORONTO — Some of the most active companies traded Wednesday on the Toronto Stock Exchange:Toronto Stock Exchange (17,005.82, down 5.58 points.)Aurora Cannabis Inc. (TSX:ACB). Health care. Up 39 cents, or 12.54 per cent, to $3.50 on 28.4 million shares.Cenovus Energy Inc. (TSX:CVE). Energy. Up five cents, or 0.42 per cent, to $11.86 on 8.3 million shares.Encana Corp. (TSX:ECA). Energy. Up 16 cents, or 3.04 per cent, to $5.42 on 8 million shares.The Green Organic Dutchman Holdings. (TSX:TGOD). Health care. Up 16 cents, or 21.92 per cent, to 89 cents on 6.9 million shares.Canopy Growth Corp. (TSX:WEED). Health care. Up $3.18, or 15.66 per cent, to $23.49 on 6.7 million shares.Aphria Inc. (TSX:APHA). Health care. Up 31 cents, or 5.46 per cent, to $5.99 on 6.1 million shares. Companies in the news:Canadian National Railway Co. (TSX:CNR). Down $2.20 or 1.8 per cent to $120.45. A chronic shortage of truck drivers across Canada is compounding concerns about the impact of a strike at Canadian National Railway Co., says the Forest Products Association of Canada. The forest industry supplies about 10 per cent of the tonnage transported on Canada's railway system, CEO Derek Nighbor said, adding his industry is already reeling from a downturn that has resulted in several mill shutdowns and hundreds of layoffs in British Columbia. The strike by roughly 3,200 Teamsters Canada Rail Conference members began after the union and company failed to reach a deal by a Monday midnight deadline.Metro Inc. (TSX:MRU). Up 74 cents or 1.3 per cent to $55.98. Metro Inc. plans to roughly double the number stores with self checkouts during its 2020 financial year as the industry contends with a tight labour market. CEO Eric La Fleche said the company is managing through the problem so far but he noted at a certain point, if staff don't show up or stores can't find people to fill vacancies, store conditions start to reflect that reality. More than 100 Metro stores already have self checkouts installed and the company plans to add the technology to another 100 locations this fiscal year, he said.Encana Corp. (TSX:ECA). — The CEO of Encana Corp. is firing back after Canadian investment manager Letko, Brosseau & Associates Inc. said it would vote its four per cent stake against the Calgary-based company's planned headquarters move to Denver. Doug Suttles, a Texan who lives in Denver, says the company is "disappointed" by the investor's stance against what he says is a "crystal clear" rationale to expose the company to growing pools of investment from U.S. index funds and passively managed accounts. He says he disagrees with Letko Brosseau's assertion that the move means investors holding Encana through indexed Canadian funds or with Canadian-only investment policies would have to sell shares, thus compounding recent share price deterioration.This report by The Canadian Press was first published Nov. 20, 2019. The Canadian Press
A wave of disappointing earnings caused a bloodbath in marijuana ETFs last week. However, talks of an end to the federal embargo on marijuana could turn this segment around.
The Zacks Analyst Blog Highlights: JPMorgan Chase, Altria, ConocoPhillips, The Travelers Companies and Twitter
The traditional approaches to retirement planning are longer covering all expenses in nest egg years. So what can retirees do? Thankfully, there are alternative investments that provide steady, higher-rate income streams to replace dwindling bond yields.
Myovant's (MYOV) phase III study evaluating lead pipeline candidate, relugolix, in patients with advanced prostate cancer meets primary endpoint.
Top cannabis players have lost 75% in market value over the last year. Here's why investors can expect weakness to continue in the short-term.
Investing.com – Canopy Growth has plunged in recent months to levels that finally make it worth buying, Bank of America said on Wednesday, sending shares of the Canadian cannabis producer sharply higher.
On Nov. 14, Canopy CGC reported second-quarter results highlighted by product mix challenges due to an unexpected and dramatic hit to revenue and profits. After overproducing oil and softgel for the Canadian recreational market, the company had to accept returns and price reductions that led to a CAD 33 million restructuring charge. Kilogram equivalents sold increased 397% year over year to 10,913 kilograms, which the Canadian recreational market and international medical market boosted.
If you want to know who really controls Canopy Growth Corporation (TSE:WEED), then you'll have to look at the makeup...